BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2966036)

  • 1. Evidence for a role of endorphins in the cardiovascular pathophysiology of primate shock.
    Gurll NJ; Reynolds DG; Holaday JW
    Crit Care Med; 1988 May; 16(5):521-30. PubMed ID: 2966036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opiate receptors and endorphins in the pathophysiology of hemorrhagic shock.
    Gurll NJ; Vargish T; Reynolds DG; Lechner RB
    Surgery; 1981 Mar; 89(3):364-9. PubMed ID: 6258256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyrotropin releasing hormone: effects in monkeys and dogs subjected to experimental circulatory shock.
    Gurll NJ; Holaday JW; Reynolds DG; Ganes E
    Crit Care Med; 1987 Jun; 15(6):574-81. PubMed ID: 3105962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central nervous system is involved in the cardiovascular responses to naloxone in canine endotoxic but not hemorrhagic shock.
    Gurll NJ; Ganes E; Reynolds DG
    Circ Shock; 1987; 22(2):115-25. PubMed ID: 3594733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naloxone without transfusion prolongs survival and enhances cardiovascular function in hypovolemic shock.
    Gurll NJ; Reynolds DG; Vargish T; Lechner R
    J Pharmacol Exp Ther; 1982 Mar; 220(3):621-4. PubMed ID: 7062272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endorphins in primate hemorrhagic shock: beneficial action of opiate antagonists.
    McIntosh TK; Palter M; Grasberger R; Vezina R; Gerstein L; Yeston N; Egdahl RH
    J Surg Res; 1986 Mar; 40(3):265-75. PubMed ID: 2936929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naloxone reversal of hypovolemic shock in dogs.
    Vargish T; Reynolds DG; Gurll NJ; Lechner RB; Holaday JW; Faden AI
    Circ Shock; 1980; 7(1):31-8. PubMed ID: 6248264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of temperature on naloxone treatment in canine hemorrhagic shock.
    Horton JW; Tuggle DW; Kiser RS
    Circ Shock; 1984; 14(4):251-65. PubMed ID: 6096039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naloxone in endotoxic shock: experimental models and clinical perspective.
    Gurll N
    Adv Shock Res; 1983; 10():63-71. PubMed ID: 6308974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of hemorrhagic shock and endotoxin shock on plasma levels of beta-endorphin and beta-lipotropin.
    Oyama T; Yao M; Ishihara H; Kudo T; Kudo M; Matsuki A
    Prog Clin Biol Res; 1983; 111():185-96. PubMed ID: 6306679
    [No Abstract]   [Full Text] [Related]  

  • 11. Naloxone requires circulating catecholamines to attenuate the cardiovascular suppression of endotoxic shock.
    Allgood SC; Gurll NJ; Reynolds DG
    J Surg Res; 1988 Jan; 44(1):73-81. PubMed ID: 3336212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-dependent effects of nalbuphine in canine hemorrhagic shock.
    Hunt LB; Gurll NJ; Reynolds DG
    Circ Shock; 1984; 13(4):307-18. PubMed ID: 6090033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of endorphins and vasopressin in canine endotoxin shock.
    Cronenwett JL; Baver-Neff BS; Grekin RJ; Sheagren JN
    J Surg Res; 1986 Dec; 41(6):609-19. PubMed ID: 2946895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of an opiate antagonist (naloxone) and an agonist/antagonist (nalbuphine) in primate hemorrhagic shock: relationship to catecholamine release.
    McIntosh TK; Palter M; Grasberger R; Vezina R; Yeston NS; Egdahl RH
    Circ Shock; 1985; 17(4):313-25. PubMed ID: 4092345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naloxone pretreatment prevents the bloody diarrhea of canine endotoxic shock.
    Ganes E; Gurll NJ; Reynolds DG
    Proc Soc Exp Biol Med; 1987 Mar; 184(3):267-77. PubMed ID: 3823104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The therapeutic efficacy of opiate antagonists in hemorrhagic shock.
    Reynolds DG; Gurll NJ; Holaday JW; Lechner RB
    Resuscitation; 1989 Dec; 18(2-3):243-51. PubMed ID: 2555877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracoronary naloxone in hemorrhagic shock: dose-dependent stereospecific effects.
    Lechner RB; Gurll NJ; Reynolds DG
    Am J Physiol; 1985 Aug; 249(2 Pt 2):H272-7. PubMed ID: 4025562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naltrexone improves survival rate and cardiovascular function in canine hemorrhagic shock.
    Gurll NJ; Reynolds DG; Vargish T; Lechner R
    J Pharmacol Exp Ther; 1982 Mar; 220(3):625-8. PubMed ID: 6278127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of naloxone on endotoxic and hemorrhagic shock in horses.
    Weld JM; Kamerling SG; Combie JD; Nugent TE; Woods WE; Oeltgen P; Tobin T
    Res Commun Chem Pathol Pharmacol; 1984 May; 44(2):227-38. PubMed ID: 6739953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormone changes and beta-endorphin in the pathogenesis of hemorrhagic shock.
    Machuganska A; Zaharieva S
    Acta Physiol Pharmacol Bulg; 1985; 11(1):26-33. PubMed ID: 2930996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.